QSP Modeling to Inform Dose & Regimen Selection for TAK-280: A Bi-specific Antibody
- Both QW and BIW dosing led to comparable predicted safety outcome
- Immune cell dynamics reveal the key role of de-sensitization in driving attenuation of cytokine Cmax